Back to Journals » Cancer Management and Research » Volume 11

Nivolumab plus ipilimumab combination therapy for the first-line treatment NSCLC: evidence to date

Total article views   Abstract views HTML views PDF downloads Totals
3,149 Dovepress* 1,627 452+ 716 2,079
PubMed Central* 0 1,070 251 1,070
Totals 1,627 1,522 967 3,149
*Since 29 May 2019
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 1 1 3

View citations on PubMed Central and Google Scholar